## **Core Concept**
Varicella-zoster immunoglobulin (VariZIG) is used for post-exposure prophylaxis of varicella (chicken-pox) in high-risk individuals. This includes immunocompromised patients, pregnant women, and newborns. The goal is to prevent or modify the disease in those who are at increased risk of severe varicella.

## **Why the Correct Answer is Right**
The correct use of varicella-zoster immunoglobulin involves administering it within a specific timeframe after exposure to varicella-zoster virus. It is most effective when given within 96 hours (4 days) of exposure. This timeframe allows for the passive transfer of antibodies to provide temporary protection against the development of varicella or to modify its severity.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might include statements about the timing, population, or efficacy of varicella-zoster immunoglobulin that are not accurate.
- **Option B:** Similarly, without the specific content, we can infer that any statement contradicting established guidelines on the use of varicella-zoster immunoglobulin, such as incorrect timing (e.g., > 96 hours post-exposure), wrong populations (e.g., healthy children), or incorrect dosing, would be wrong.
- **Option C:** This would also be incorrect based on similar reasoning as Option B.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that varicella-zoster immunoglobulin is effective for post-exposure prophylaxis when administered within 96 hours of exposure. This is particularly important for high-risk individuals who may develop severe disease.

## **Correct Answer:** D. Within 96 hours.